{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T20:53:48Z","timestamp":1768510428753,"version":"3.49.0"},"posted":{"date-parts":[[2024,3,29]]},"group-title":"Pharmacology and Toxicology","reference-count":50,"publisher":"openRxiv","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,4,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>S1P (sphingosine 1-phosphate) receptor modulator (SRM) drugs interfere with lymphocyte trafficking by downregulating lymphocyte S1P receptors. While the immunosuppressive activity of SRM drugs has proved useful in treating autoimmune diseases such as multiple sclerosis, that drug class is beset by on-target liabilities such as initial dose bradycardia. The S1P that binds to cell surface lymphocyte S1P receptors is provided by S1P transporters. Mice born deficient in one of these, spinster homolog 2 (Spns2), are lymphocytopenic and have low lymph S1P concentrations. Such observations suggest that inhibition of Spns2-mediated S1P transport might provide another therapeutically beneficial method to modulate immune cell positioning. We report here results using a novel S1P transport blocker (STB), SLF80821178, to investigate the consequences of S1P transport inhibition in rodents. We found that SLF80821178 is efficacious in a multiple sclerosis model but \u2013 unlike the SRM fingolimod \u2013 neither decreases heart rate nor compromises lung endothelial barrier function. Notably, although Spns2 null mice have a sensorineural hearing defect, mice treated chronically with SLF80821178 have normal hearing acuity. STBs such as SLF80821178 evoke a dose-dependent decrease in peripheral blood lymphocyte counts, which affords a reliable pharmacodynamic marker of target engagement. However, the maximal reduction in circulating lymphocyte counts in response to SLF80821178 is substantially less than the response to SRMs such as fingolimod (50% vs. 90%) due to a lesser effect on T lymphocyte sub-populations by SLF80821178. Finally, in contrast to results obtained with Spns2 deficient mice, lymph S1P concentrations were not significantly changed in response to administration of STBs at doses that evoke maximal lymphopenia, which indicates that current understanding of the mechanism of action of S1P transport inhibitors is incomplete.<\/jats:p>","DOI":"10.1101\/2024.03.26.586765","type":"posted-content","created":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T20:25:27Z","timestamp":1711743927000},"source":"Crossref","is-referenced-by-count":0,"title":["Assessing Spns2-dependent S1P Transport as a Prospective Therapeutic Target"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9241-6860","authenticated-orcid":false,"given":"Y","family":"Kharel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8755-1478","authenticated-orcid":false,"given":"K","family":"Dunnavant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Foster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4678-6910","authenticated-orcid":false,"given":"GMPR","family":"Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4335-2523","authenticated-orcid":false,"given":"KE","family":"Nimchuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0180-6044","authenticated-orcid":false,"given":"AR","family":"Merchak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7470-7285","authenticated-orcid":false,"given":"CM","family":"Pavelec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ZJ","family":"Juskiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4175-6053","authenticated-orcid":false,"given":"A","family":"Gaultier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1244-3637","authenticated-orcid":false,"given":"SBG","family":"Abbott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3047-0874","authenticated-orcid":false,"given":"J-B","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7692-6294","authenticated-orcid":false,"given":"BE","family":"Isakson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6224-5175","authenticated-orcid":false,"given":"N","family":"Leitinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4731-8548","authenticated-orcid":false,"given":"WL","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7376-922X","authenticated-orcid":false,"given":"KR","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2024050402450652000_2024.03.26.586765v2.1","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1600-6143.2004.00476.x","article-title":"FTY720: sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier function","volume":"4","year":"2004","journal-title":"American J Transplantation"},{"key":"2024050402450652000_2024.03.26.586765v2.2","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s40264-021-01057-z","article-title":"Safety of S1P modulators in patients with immune-mediated diseases: A systematic review and meta analysis","volume":"44","year":"2021","journal-title":"Drug Safety"},{"key":"2024050402450652000_2024.03.26.586765v2.3","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1084\/jem.20102551","article-title":"Lipid phosphate phosphatase 3 enables efficient thymic egress","volume":"208","year":"2011","journal-title":"J Experimental Medicine"},{"key":"2024050402450652000_2024.03.26.586765v2.4","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000122383.60368.24"},{"key":"2024050402450652000_2024.03.26.586765v2.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcdb.2004.05.007"},{"key":"2024050402450652000_2024.03.26.586765v2.6","doi-asserted-by":"publisher","DOI":"10.1177\/0192623314565650"},{"key":"2024050402450652000_2024.03.26.586765v2.7","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.064162"},{"key":"2024050402450652000_2024.03.26.586765v2.8","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.slasd.2023.07.001","article-title":"Assay of sphingosine 1-phosphate transporter spinster homolog 2 (Spns2) inhibitors","volume":"28","year":"2023","journal-title":"SLAS Discovery"},{"key":"2024050402450652000_2024.03.26.586765v2.9","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.1038\/s41598-018-23300-x","article-title":"MFSD2B is a sphingosine 1-phosphate transporter in erythroid cells","volume":"8","year":"2018","journal-title":"Science Reports"},{"key":"2024050402450652000_2024.03.26.586765v2.10","doi-asserted-by":"publisher","DOI":"10.1038\/nature24053"},{"key":"2024050402450652000_2024.03.26.586765v2.11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0038941"},{"issue":"658","key":"2024050402450652000_2024.03.26.586765v2.12","doi-asserted-by":"crossref","first-page":"eabj2681","DOI":"10.1126\/scitranslmed.abj2681","article-title":"S1P signaling in perivascular cells enhances inflammation and fibrosis in the kidney","volume":"14","year":"2022","journal-title":"Science Translational Medicine"},{"key":"2024050402450652000_2024.03.26.586765v2.13","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/s41586-021-03227-6","article-title":"Monocyte-derived S1P in the lymph node regulates immune responses","volume":"592","year":"2021","journal-title":"Nature"},{"key":"2024050402450652000_2024.03.26.586765v2.14","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/glia.23558","article-title":"Lipid transporter Spns2 promotes microglia pro-inflammatory activation in response to amyloid-beta peptide","volume":"67","year":"2019","journal-title":"Glia"},{"key":"2024050402450652000_2024.03.26.586765v2.15","first-page":"102","article-title":"Role of sphingosine-1-phosphate transporter Spns2 in immune system function","volume":"89","year":"2012","journal-title":"J Immunology"},{"key":"2024050402450652000_2024.03.26.586765v2.16","doi-asserted-by":"publisher","DOI":"10.1172\/JCI60746"},{"key":"2024050402450652000_2024.03.26.586765v2.17","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.celrep.2012.09.021","article-title":"The transporter Spns2 is required for secretion of lymph but not plasma sphingosine-1-phosphate","volume":"2","year":"2012","journal-title":"Cell Reports"},{"key":"2024050402450652000_2024.03.26.586765v2.18","doi-asserted-by":"crossref","first-page":"e41239","DOI":"10.7554\/eLife.41239","article-title":"High-endothelial cell-derived S1P regulates dendritic cell localization and vascular integrity in the lymph node","volume":"8","year":"2019","journal-title":"eLife"},{"key":"2024050402450652000_2024.03.26.586765v2.19","doi-asserted-by":"crossref","unstructured":"Hasan Z , Nguyen TQ , Lam BWS , Wong JHX , Wong CCY , Tan CKH , Yu J , Thiam CH , Zhang Y , Angeli V , Nguyen LN . Postnatal deletion of Spns2 prevents neuroinflammation without compromising blood vascular function. Cellular Molecular Life Sciences 79, 541 (2002)","DOI":"10.1007\/s00018-022-04573-y"},{"key":"2024050402450652000_2024.03.26.586765v2.20","doi-asserted-by":"crossref","first-page":"7656","DOI":"10.1021\/acs.jmedchem.1c02171","article-title":"Discovery of in vivo active sphingosine 1-phosphate transporter Spns2 inhibitors","volume":"65","year":"2022","journal-title":"J Medicinal Chemistry"},{"key":"2024050402450652000_2024.03.26.586765v2.21","doi-asserted-by":"crossref","first-page":"5873","DOI":"10.1021\/acs.jmedchem.3c00149","article-title":"2-Aminobenzoxazole derivatives as potent inhibitors of the sphingosine 1-phosphate transporter spinster homolog 2 (Spns2)","volume":"66","year":"2023","journal-title":"J Medicinal Chemistry"},{"key":"2024050402450652000_2024.03.26.586765v2.22","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1124\/jpet.102.045658","article-title":"Amelioration of experimental autoimmune encephalomyelitis in Lewis rats by FTY720 treatment","volume":"305","year":"2003","journal-title":"J Pharmacology & Experimental Therapeutics"},{"key":"2024050402450652000_2024.03.26.586765v2.23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2012.02061.x"},{"key":"2024050402450652000_2024.03.26.586765v2.24","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.3390\/cells9051290","article-title":"Central modulation of selective sphingosine-1-phosphate receptor 1 ameliorates experimental multiple sclerosis","volume":"9","year":"2020","journal-title":"Cells"},{"key":"2024050402450652000_2024.03.26.586765v2.25","first-page":"22","article-title":"Therapeutic potential of ponesimod alone and in combination with dimethyl fumarate in experimental models of multiple sclerosis","volume":"16","year":"2019","journal-title":"Innovations in Clinical Neuroscience"},{"key":"2024050402450652000_2024.03.26.586765v2.26","first-page":"1313","article-title":"Discovery of APD334: Design of a clinical stage functional antagonist of the sphingosine-1-phosphate-1 receptor","volume":"4","year":"2014","journal-title":"ACS Medicinal Chemistry Letters"},{"key":"2024050402450652000_2024.03.26.586765v2.27","doi-asserted-by":"crossref","first-page":"109368","DOI":"10.1016\/j.celrep.2021.109368","article-title":"Spns2 enables T-cell egress from lymph nodes during an immune response","volume":"36","year":"2021","journal-title":"Cell Reports"},{"key":"2024050402450652000_2024.03.26.586765v2.28","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1600-6143.2005.00754.x","article-title":"The heart rate decrease caused by acute FTY720 administration is mediated by the G protein-gated potassium channel I","volume":"5","year":"2005","journal-title":"American J Transplantation"},{"key":"2024050402450652000_2024.03.26.586765v2.29","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M311743200"},{"key":"2024050402450652000_2024.03.26.586765v2.30","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.pupt.2011.01.017","article-title":"The sphingosine-1 phosphate receptor agonist FTY720 dose dependently affected endothelial integrity in vitro and aggravated ventilator-induced lung injury in mice","volume":"24","year":"2011","journal-title":"Pulmonary Pharmacology & Therapeutics"},{"key":"2024050402450652000_2024.03.26.586765v2.31","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1021\/acs.jmedchem.8b01695","article-title":"Identification and preclinical pharmacology of ((1R,S)-1-amino-3-((S)-6-(2-methoxyphenethyl)-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopentyl)methanol (BMS-986166): A differential sphingosine-1-phosphate receptor 1 (S1P1) modulator advanced into clinical trials","volume":"62","year":"2019","journal-title":"J Medicinal Chemistry"},{"key":"2024050402450652000_2024.03.26.586765v2.32","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M700370200"},{"key":"2024050402450652000_2024.03.26.586765v2.33","doi-asserted-by":"crossref","first-page":"e1004688","DOI":"10.1371\/journal.pgen.1004688","article-title":"Spinster homolog 2 (Spns2) deficiency causes early onset progressive hearing loss","volume":"10","year":"2014","journal-title":"PLoS Genetics"},{"key":"2024050402450652000_2024.03.26.586765v2.34","doi-asserted-by":"crossref","first-page":"104658","DOI":"10.1016\/j.ejmg.2022.104658","article-title":"Compound heterozygous variants in SPNS2 cause sensorineural hearing loss","volume":"66","year":"2023","journal-title":"European J Medical Genetics"},{"key":"2024050402450652000_2024.03.26.586765v2.35","doi-asserted-by":"crossref","unstructured":"Le TNU , Nguyen TQ , Kalailingam P , Nguyen YTK , Sukumar VK , Tan CKH , Tukijan F , Couty L , Hasan Z , Gaudio ID , Wenk MR , Cazenave-Gassiot A , Camerer E , Nguyen LN . Mfsd2b and Spns2 are essential for maintenance of blood vessels during development and in anaphylactic shock. Cell Reports 40, 111208 (2022)","DOI":"10.1016\/j.celrep.2022.111208"},{"key":"2024050402450652000_2024.03.26.586765v2.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.cub.2008.10.061"},{"key":"2024050402450652000_2024.03.26.586765v2.37","doi-asserted-by":"publisher","DOI":"10.1126\/science.1167449"},{"key":"2024050402450652000_2024.03.26.586765v2.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2022.12.021"},{"key":"2024050402450652000_2024.03.26.586765v2.39","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-3616536\/v1"},{"key":"2024050402450652000_2024.03.26.586765v2.40","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-023-00908-x"},{"key":"2024050402450652000_2024.03.26.586765v2.41","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-023-00913-0"},{"key":"2024050402450652000_2024.03.26.586765v2.42","doi-asserted-by":"crossref","unstructured":"Garcia-Seyda N , Song S , de Noray VS , David-Broglio L , Matti C , Artinger M , Dupuy F , Biarnes-Pelicot M , Valignat M-P , Legler DF , Baj\u00e9noff M , Theodoly O . Na\u00efve T lymphocytes chemotax long distance to CCL21 but not to a source of bioactive S1P. iScience 26, 107695 (2023)","DOI":"10.1016\/j.isci.2023.107695"},{"key":"2024050402450652000_2024.03.26.586765v2.43","doi-asserted-by":"publisher","DOI":"10.1038\/ni1269"},{"key":"2024050402450652000_2024.03.26.586765v2.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ab.2011.01.003"},{"key":"2024050402450652000_2024.03.26.586765v2.45","doi-asserted-by":"crossref","first-page":"e3002000","DOI":"10.1371\/journal.pbio.3002000","article-title":"The activity of the aryl hydrocarbon receptor in T cells tunes the gut microenvironment to systain autoimunity and neuroinflammation","volume":"21","year":"2023","journal-title":"PloS Biology"},{"key":"2024050402450652000_2024.03.26.586765v2.46","doi-asserted-by":"crossref","first-page":"e72681","DOI":"10.7554\/eLife.72681","article-title":"Repair of noise-induced damage to stereocilia F-actin cores is facilitated by XIRP2 and its novel mechanosensor domain","volume":"12","year":"2023","journal-title":"eLife"},{"key":"2024050402450652000_2024.03.26.586765v2.47","doi-asserted-by":"crossref","first-page":"e00219","DOI":"10.1016\/j.heliyon.2016.e00219","article-title":"Sphingosine-1-phosphate in the lymphatic fluid determined by novel methods","volume":"2","year":"2016","journal-title":"Heliyon"},{"key":"2024050402450652000_2024.03.26.586765v2.48","doi-asserted-by":"crossref","first-page":"8533","DOI":"10.1007\/s00216-015-9008-4","article-title":"Quantification of sphingosine 1-phosphate by validated LC-MS\/MS method revealing strong correlation with apolipoprotein M in plasma but not in serum due to platelet activation during blood coagulation","volume":"407","year":"2015","journal-title":"Analytical Bioanalytical Chemistry"},{"key":"2024050402450652000_2024.03.26.586765v2.49","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20110817"},{"key":"2024050402450652000_2024.03.26.586765v2.50","first-page":"149","article-title":"Sphingosine kinase type 2 inhibition elevates circulating sphingosine 1-phosphate","volume":"477","year":"2012","journal-title":"Biochemical J"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2024.03.26.586765","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T06:11:51Z","timestamp":1768457511000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2024.03.26.586765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,29]]},"references-count":50,"URL":"https:\/\/doi.org\/10.1101\/2024.03.26.586765","relation":{},"subject":[],"published":{"date-parts":[[2024,3,29]]},"subtype":"preprint"}}